Product Description
Taxeleon 260 mg Injection is an anticancer medicine. It treats breast cancer, non-small cell lung cancer, ovarian cancer, and AIDS (Acquired Immuno-Deficiency Syndrome). Cancer is a condition in which cells are dividing and growing fast and in an uncontrolled manner. This Injection may be given alone or in combination with other anticancer medicines. It should not be used for severe liver problems, uncontrolled infection, and low white blood cell or platelet count.
Taxeleon 260 mg is not recommended for adolescents and children under the age of 18. Talk to your doctor if you have heart disorders before taking this medicine. Administration of this medicine can cause serious allergic reactions. Use effective birth control during the treatment and for at least six months after the last dose. This Injection may harm patients suffering from alcoholism as this medicine contains alcohol.
Key IndicationsTaxeleon 260mg Injection is an effective chemotherapeutic agent used to treat a variety of cancers, including breast cancer, non-small cell lung cancer, prostate cancer, gastric cancer, and cancers of the head and neck. Its broad spectrum makes it a critical therapeutic option in oncology management.
Safe AdministrationThis medication is for intravenous use only and should be administered by trained medical personnel. It may require dilution with appropriate solvents, such as 0.9% Sodium Chloride Injection or 5% Dextrose Injection, before administration. Accurate dosing and monitoring are crucial for optimal outcomes.
Monitoring and PrecautionsDue to potential risks like neutropenia and hypersensitivity reactions, patients receiving Taxeleon 260mg require vigilant monitoring throughout treatment. Your healthcare provider will schedule regular checkups to assess blood counts and monitor for any adverse effects, ensuring safe and effective therapy.
FAQ's of Taxeleon 260mg Injection:
Q: How is Taxeleon 260mg Injection administered?
A: Taxeleon 260mg Injection is administered intravenously, typically after dilution with either 0.9% Sodium Chloride Injection or 5% Dextrose Injection. The preparation and administration should only be performed by qualified medical professionals in a clinical setting.
Q: What types of cancer is Taxeleon 260mg Injection used to treat?
A: This injection is primarily indicated for the treatment of breast cancer, non-small cell lung cancer, prostate cancer, gastric cancer, and head and neck cancers. The specific use depends on the patient's condition and doctor's assessment.
Q: When should Taxeleon 260mg Injection be given?
A: The timing and frequency of administration are determined by your healthcare provider, based on the type and stage of cancer, as well as the patient's response to therapy. Follow your doctor's prescribed treatment schedule closely.
Q: Where should Taxeleon 260mg Injection be stored?
A: Taxeleon 260mg should be stored in a cool, dry place, away from direct sunlight and heat, to preserve its efficacy. Always keep the vial out of reach of children and only use it before the expiration date specified by the manufacturer.
Q: What precautions should be taken during Taxeleon 260mg Injection therapy?
A: Common precautions include monitoring for neutropenia (low white blood cell count) and hypersensitivity reactions. Regular blood tests and close supervision by healthcare professionals are important to manage and mitigate potential side effects.
Q: What are the benefits of using Taxeleon 260mg Injection?
A: Taxeleon 260mg offers targeted treatment for several major cancers, potentially improving survival rates and contributing to better disease management. It is an established chemotherapy agent with proven clinical efficacy when used as directed.
Q: Is any special solvent required to prepare Taxeleon 260mg Injection?
A: Yes, Taxeleon 260mg Injection may require dilution with a suitable solvent such as 0.9% Sodium Chloride or 5% Dextrose Injection prior to intravenous administration. Only trained personnel should handle the preparation and administration process.